Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,987 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reply by Authors.
Kobayashi S, Cho B, Mutaguchi J, Inokuchi J, Tatsugami K, Hashizume M, Eto M. Kobayashi S, et al. J Urol. 2020 Jul;204(1):156. doi: 10.1097/JU.0000000000000709.02. Epub 2020 Apr 23. J Urol. 2020. PMID: 32324094 No abstract available.
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate Cancer.
Yamashita T, Shiota M, Machidori A, Kobayashi S, Matsumoto T, Monji K, Kashiwagi E, Takeuchi A, Takahashi R, Inokuchi J, Shiga KI, Yokomizo A, Eto M. Yamashita T, et al. Among authors: kobayashi s. Cancer Invest. 2021 Mar;39(3):251-256. doi: 10.1080/07357907.2020.1871486. Epub 2021 Jan 14. Cancer Invest. 2021. PMID: 33393849 Clinical Trial.
Salvage robot-assisted radical prostatectomy after carbon ion radiotherapy: a case report.
Kobayashi H, Kobayashi S, Shiota M, Takamatsu D, Abe T, Kashiwagi E, Takeuchi A, Inokuchi J, Kohashi K, Shioyama Y, Oda Y, Eto M. Kobayashi H, et al. Among authors: kobayashi s. Int Cancer Conf J. 2021 Jan 3;10(2):96-99. doi: 10.1007/s13691-020-00464-w. eCollection 2021 Apr. Int Cancer Conf J. 2021. PMID: 33786284 Free PMC article.
Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patients.
Kobayashi H, Shiota M, Sato N, Kobayashi S, Matsumoto T, Monji K, Kashiwagi E, Takeuchi A, Inokuchi J, Shiga KI, Yokomizo A, Eto M. Kobayashi H, et al. Among authors: kobayashi s. Anticancer Drugs. 2022 Jan 1;33(1):e541-e547. doi: 10.1097/CAD.0000000000001170. Anticancer Drugs. 2022. PMID: 34387597
9,987 results